AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Anti-Müllerian hormone levels and related factors of 715 HIV-infected women in childbearing ageView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020The impact of gender on the clinical course of HIV infection in Yangon, MyanmarView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Safety and Efficacy of Genvoya® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide, EVG/C/F/TAF) from the 3rd year Post Market Surveillance (PMS) Data in KoreaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Treatment Persistence among HIV-1 Patients Initiating Antiretroviral Therapy in JapanView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Assessment of the safety of dolutegravir in HIV-infected patients from China: A real-world, open-label, multicenter, post-marketing surveillance studyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Women living with HIVView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Pooled Analysis of the Efficacy, Safety, and Health Outcomes Following 48 Weeks of Long-acting Cabotegravir and Rilpivirine Maintenance Therapy for HIV-1 Infection in Phase 3 ATLAS and FLAIR Studies: Sub-Analysis in Asian PopulationsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Adults Living with HIVView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Durable efficacy of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral treatment–naive adults with HIV-1 infection: 96-week results from the GEMINI studies in participants from Asian centresView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Drug resistance to novel non-nucleoside reverse transcriptase inhibitor Elsulfavirine among treatment-naïve, HIV-infected Caucasian and Asian patientsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Cost-Saving of Pooled HCV RNA Testing to Diagnose Acute HCV Infection in High-Risk PopulationsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Associated factors with sexually transmitted hepatitis C virus infection among HIV-positive men who have sex with men in TaiwanView Abstract
